Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection

References

• Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12:298-306; PMID:22419253; http://dx.doi.org/10.1038/nrc3245
   PubMed Web of Science ®Google Scholar
• Ryschich E, Schmidt J, Hammerling GJ, Klar E, Ganss R. Transformation of the microvascular system during multistage tumorigenesis. Int J Cancer 2002; 97:719-25; PMID:11857345; http://dx.doi.org/10.1002/ijc.10074
   PubMed Web of Science ®Google Scholar
• Hamzah J, Jugold M, Kiessling F, Rigby P, Manzur M, Marti HH, Rabie T, Kaden S, Grone HJ, Hammerling GJ et al. Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 2008; 453:410-4; PMID:18418378; http://dx.doi.org/10.1038/nature06868
   PubMed Web of Science ®Google Scholar
• Garbi N, Arnold B, Gordon S, Hammerling GJ, Ganss R. CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction. J Immunol 2004; 172:5861-9; PMID:15128765; http://dx.doi.org/10.4049/jimmunol.172.10.5861
   PubMed Web of Science ®Google Scholar
• Ganss R, Ryschich E, Klar E, Arnold B, Hammerling GJ. Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. Cancer Res 2002; 62:1462-70; PMID:11888921
   PubMed Web of Science ®Google Scholar
• Cao ZA, Daniel D, Hanahan D. Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer. BMC Cancer 2002; 2:11; PMID:12019035; http://dx.doi.org/10.1186/1471-2407-2-11
   PubMed Web of Science ®Google Scholar
• Klug F, Prakash H, Huber PE, Seibel T, Bender N, Halama N, Pfirschke C, Voss RH, Timke C, Umansky L et al. Low-dose irradiation programs macrophage differentiation to an iNOS(+)/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell 2013; 24:589-602; PMID:24209604; http://dx.doi.org/10.1016/j.ccr.2013.09.014
   PubMed Web of Science ®Google Scholar
• Bogdan C. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol 2015; 36:161-78; PMID:25687683; http://dx.doi.org/10.1016/j.it.2015.01.003
   PubMed Web of Science ®Google Scholar
• Liew FY. Regulation of lymphocyte functions by nitric oxide. Curr Opin Immunol 1995; 7:396-9; PMID:7546406; http://dx.doi.org/10.1016/0952-7915(95)80116-2
   PubMed Web of Science ®Google Scholar
• Umansky V, Schirrmacher V. Nitric oxide-induced apoptosis in tumor cells. Adv Cancer Res 2001; 82:107-31; PMID:11447761; http://dx.doi.org/10.1016/S0065-230X(01)82004-2
   PubMed Web of Science ®Google Scholar
• Spiecker M, Peng HB, Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem 1997; 272:30969-74; PMID:9388244; http://dx.doi.org/10.1074/jbc.272.49.30969
   PubMed Web of Science ®Google Scholar
• Waldow T, Witt W, Weber E, Matschke K. Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NFkappaB activation in endothelial cells. Nitric Oxide 2006; 15:103-13; PMID:16504556; http://dx.doi.org/10.1016/j.niox.2005.12.005
   PubMed Web of Science ®Google Scholar
• Lee SK, Kim JH, Yang WS, Kim SB, Park SK, Park JS. Exogenous nitric oxide inhibits VCAM-1 expression in human peritoneal mesothelial cells. Role of cyclic GMP and NF-kappaB. Nephron 2002; 90:447-54; PMID:11961404; http://dx.doi.org/10.1159/000054733
   PubMed Web of Science ®Google Scholar
• Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Pro Natl Acad Sci U S A 1996; 93:9114-9; PMID:8799163; http://dx.doi.org/10.1073/pnas.93.17.9114
   PubMed Web of Science ®Google Scholar
• Bouzin C, Brouet A, De Vriese J, Dewever J, Feron O. Effects of vascular endothelial growth factor on the lymphocyte-endothelium interactions: identification of caveolin-1 and nitric oxide as control points of endothelial cell anergy. J Immunol 2007; 178:1505-11; PMID:17237399; http://dx.doi.org/10.4049/jimmunol.178.3.1505
   PubMed Web of Science ®Google Scholar
• Ridnour LA, Cheng RY, Weiss JM, Kaur S, Soto-Pantoja DR, Basudhar D, Heinecke JL, Stewart CA, DeGraff W, Sowers AL et al. NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay. Cancer Res 2015; 75:2788-99; PMID:25990221; http://dx.doi.org/10.1158/0008-5472.CAN-14-3011
   PubMed Web of Science ®Google Scholar
• Liu Q, Tomei S, Ascierto ML, De Giorgi V, Bedognetti D, Dai C, Uccellini L, Spivey T, Pos Z, Thomas J et al. Melanoma NOS1 expression promotes dysfunctional IFN signaling. J Clin Invest 2014; 124:2147-59; PMID:24691438; http://dx.doi.org/10.1172/JCI69611
   PubMed Web of Science ®Google Scholar
• Hanahan D. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985; 315:115-22; PMID:2986015; http://dx.doi.org/10.1038/315115a0
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23:549-55; PMID:12401408; http://dx.doi.org/10.1016/S1471-4906(02)02302-5
   PubMed Web of Science ®Google Scholar
• De Palma M, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013; 23:277-86; PMID:23518347; http://dx.doi.org/10.1016/j.ccr.2013.02.013
   PubMed Web of Science ®Google Scholar
• Carretero R, Sektioglu IM, Garbi N, Salgado OC, Beckhove P, Hammerling GJ. Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells. Nature Immunol 2015; 16:609-17; PMID:25915731; http://dx.doi.org/10.1038/ni.3159
   PubMed Web of Science ®Google Scholar
• Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, Balint K, Katsaros D, O'Brien-Jenkins A, Gimotty PA, Coukos G. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nature Med 2008; 14:28-36; PMID:18157142; http://dx.doi.org/10.1038/nm1699
   PubMed Web of Science ®Google Scholar
• Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Pro Natl Acad Sci U S A 1997; 94:6954-8; PMID:9192673; http://dx.doi.org/10.1073/pnas.94.13.6954
   PubMed Web of Science ®Google Scholar
• Bogdan C. Nitric oxide and the immune response. Nature Immunol 2001; 2:907-16; PMID:11577346; http://dx.doi.org/10.1038/ni1001-907
   PubMed Web of Science ®Google Scholar
• Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87:315-424; PMID:17237348; http://dx.doi.org/10.1152/physrev.00029.2006
   PubMed Web of Science ®Google Scholar
• Burke AJ, Sullivan FJ, Giles FJ, Glynn SA. The yin and yang of nitric oxide in cancer progression. Carcinogenesis 2013; 34:503-12; PMID:23354310; http://dx.doi.org/10.1093/carcin/bgt034
   PubMed Web of Science ®Google Scholar
• Niedbala W, Besnard AG, Nascimento DC, Donate PB, Sonego F, Yip E, Guabiraba R, Chang HD, Fukada SY, Salmond RJ et al. Nitric oxide enhances Th9 cell differentiation and airway inflammation. Nat Commun 2014; 5:4575; PMID:25099390; http://dx.doi.org/10.1038/ncomms5575
   PubMed Web of Science ®Google Scholar
• Niedbala W, Wei XQ, Piedrafita D, Xu D, Liew FY. Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur J Immunol 1999; 29:2498-505; PMID:10458764; http://dx.doi.org/10.1002/(SICI)1521-4141(199908)29:08%3c2498::AID-IMMU2498%3e3.0.CO;2-M
   PubMed Web of Science ®Google Scholar
• Umansky V, Hehner SP, Dumont A, Hofmann TG, Schirrmacher V, Droge W, Schmitz ML. Co-stimulatory effect of nitric oxide on endothelial NF-kappaB implies a physiological self-amplifying mechanism. Eur J Immunol 1998; 28:2276-82; PMID:9710205; http://dx.doi.org/10.1002/(SICI)1521-4141(199808)28:08%3c2276::AID-IMMU2276%3e3.0.CO;2-H
   PubMed Web of Science ®Google Scholar
• Duluc D, Corvaisier M, Blanchard S, Catala L, Descamps P, Gamelin E, Ponsoda S, Delneste Y, Hebbar M, Jeannin P. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int J Cancer 2009; 125:367-73; PMID:19378341; http://dx.doi.org/10.1002/ijc.24401
   PubMed Web of Science ®Google Scholar
• Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005; 307:58-62; PMID:15637262; http://dx.doi.org/10.1126/science.1104819
   PubMed Web of Science ®Google Scholar
• Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC. PloS One 2011; 6:e21874; PMID:21799753; http://dx.doi.org/10.1371/journal.pone.0021874
   PubMed Web of Science ®Google Scholar
• Ino Y, Yamazaki-Itoh R, Shimada K, Iwasaki M, Kosuge T, Kanai Y, Hiraoka N. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer 2013; 108:914-23; PMID:23385730; http://dx.doi.org/10.1038/bjc.2013.32
   PubMed Web of Science ®Google Scholar
• Edin S, Wikberg ML, Dahlin AM, Rutegard J, Oberg A, Oldenborg PA, Palmqvist R. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteri-stics of colorectal cancer. PloS One 2012; 7:e47045; PMID:23077543; http://dx.doi.org/10.1371/journal.pone.0047045
   PubMed Web of Science ®Google Scholar
• Zhang M, He Y, Sun X, Li Q, Wang W, Zhao A, Di W. A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients. J Ovarian Res 2014; 7:19; PMID:24507759; http://dx.doi.org/10.1186/1757-2215-7-19
   PubMed Web of Science ®Google Scholar
• Dannenmann SR, Thielicke J, Stockli M, Matter C, von Boehmer L, Cecconi V, Hermanns T, Hefermehl L, Schraml P, Moch H et al. Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma. Oncoimmunol 2013; 2:e23562; PMID:23687622; http://dx.doi.org/10.4161/onci.23562
   PubMed Web of Science ®Google Scholar
• Dinapoli MR, Calderon CL, Lopez DM. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. J Exp Med 1996; 183:1323-9; PMID:8666890; http://dx.doi.org/10.1084/jem.183.4.1323
   PubMed Web of Science ®Google Scholar
• Nowosielska EM, Wrembel-Wargocka J, Cheda A, Lisiak E, Janiak MK. Enhanced cytotoxic activity of macrophages and suppressed tumor metastases in mice irradiated with low doses of X- rays. J Radiat Res 2006; 47:229-36; PMID:16936416; http://dx.doi.org/10.1269/jrr.0572
   PubMed Web of Science ®Google Scholar
• Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Pro Natl Acad Sci U S A 1995; 92:10688-92; PMID:7479866; http://dx.doi.org/10.1073/pnas.92.23.10688
   PubMed Web of Science ®Google Scholar
• Li X, Kostareli E, Suffner J, Garbi N, Hammerling GJ. Efficient Treg depletion induces T-cell infiltration and rejection of large tumors. Eur J Immunol 2010; 40:3325-35; PMID:21072887; http://dx.doi.org/10.1002/eji.201041093
   PubMed Web of Science ®Google Scholar